Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MRPL37P1 (mitochondrial ribosomal protein L37 pseudogene 1) is a processed pseudogene found in humans. Pseudogenes are DNA sequences that resemble protein-coding genes but generally lack the ability to encode functional proteins due to disabling mutations or incomplete transcription/translation. MRPL37P1 derives from the mitochondrial ribosomal protein L37 gene (MRPL37), a gene involved in mitochondrial protein synthesis, but MRPL37P1 itself does not participate in this function. Most pseudogenes are transcriptionally silent, although a minority may exert regulatory effects at the RNA level (for example, through microRNA competition). At present, there is no published evidence that MRPL37P1 functions in regulation or disease, and it is not considered a drug target, receptor, enzyme, transporter, or biomarker.
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitochondrial ribosomal protein L37 pseudogene 1 (MRPL37P1).